NXR 0.00% 2.0¢ nemex resources limited

Dr. Shanny L. Dyer Recognized by Worldwide Branding for...

Currently unlisted. Proposed listing date: WITHDRAWN
  1. 4,944 Posts.
    lightbulb Created with Sketch. 166
    Dr. Shanny L. Dyer Recognized by Worldwide Branding for Excellence in Business Operations

    Dr. Shanny Dyer displays an expertise for business innovation and development strategies
    CHATSWOOD, NSW, AUSTRALIA, October 16, 2013, Dr. Shanny Dyer, Director of Seagull Technology Pty Ltd., has been recognized by Worldwide Branding for showing dedication, leadership and excellence in business growth and development.
    Dr. Dyer's career has been distinguished by excellence in business innovation across science, industry and government, where this intersection is often complex and without alignment. During the last 15 years, she has successfully led large enterprises, developed clear strategies, and delivered commercial success, motivated by delivering business results in a strategic framework that allows for creativity and innovation.
    For the last eight years, she has dedicated her industry prowess to directing Seagull Technology Pty Ltd., a medical equipment manufacturer focused on drug delivery devices. Dr. Dyer is responsible for the overall direction of the company. She manages product development, finances, and compliance with the correct governance and law. Through her work with Seagull Technology, as well as with various other entities in the past, she has become an expert in strategic management in the biotech med-tech sectors.
    In addition to serving Seagull Technology, Dr. Dyer is a business development consultant for The Garvan Institute of Medical Research. In years past, she has worked with CSIRO as a general manager of the flagship program and performance, an executive manager of major transactions and governance, and an enterprise BD manager. Even earlier than this, Dr. Dyer served Vericap Finance Ltd. as an investment manager, the University of Technology Sydney as an industry engagement and commercialization director, and Biotech Australia Pty Ltd. as a business development manager.
    Dr. Dyer holds a Ph.D. in biochemistry from Macquarie University, and she is a graduate of the Australian Institute of Company Directors. She is also a member of the Biotech/Medtech Association. She plans to not only broaden and deepen her experience in the corporate world, but also to mentor others. She aims to coach other senior executives, sharing with them her extensive experience with and knowledge of corporate governance.
    - See more at: http://www.worldwidewhoswhoreleases...xcellence-in-business-op#sthash.AgjOq1NC.dpuf
 
watchlist Created with Sketch. Add NXR (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.